FDA to launch study on drugs' effects on pregnancy

12/30/2009 | Reuters

The FDA has announced a research collaboration that will focus on the safety of drugs given to pregnant women. The Medication Exposure in Pregnancy Risk Evaluation Program was prompted by concerns about insufficient clinical trials on the issue at a time when two-thirds of women reportedly take at least one prescription drug during pregnancy.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC